Genetic Variation in the Neuropeptide Y Gene Promoter Is Associated with Increased Risk of Tobacco Smoking
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Background: Neuropeptide Y (NPY) is a strong candidate gene regarding the pathophysiology of tobacco dependence. It has been associated with various addictive and psychiatric disorders, and closely interacts with the brain reward system. The aim of the present study was to test for association between a functional genetic variant in the NP-Y promoter gene (SNP rs16147) and tobacco smoking. Methods: In a population-based case-control multicenter study designed for tobacco addiction research, a total of 550 Caucasian current smokers, and 544 never-smokers were genotyped for SNP rs16147 and behaviorally characterized with the State-Trait Anxiety Inventory (STAI). Results: Subjects with TT genotype of the SNP rs16147 were significantly more frequently smokers than never-smokers (p = 0.046). In addition, TT genotype exhibited increased state anxiety scores compared to carriers of the C allele (p = 0.037). Conclusions: Our results provide evidence for an involvement of the functionally relevant SNP rs16147 in the pathophysiology of tobacco dependence. Further studies are needed to confirm our findings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Associations were found between SNPs of the NPY Y2 receptor (NPY2R) gene and alcohol dependence, alcohol withdrawal symptoms, tobacco addiction, comorbid alcohol and cocaine dependence, and cocaine dependence (Wetherill et al., 2008;Okahisa et al., 2009;Mutschler et al., 2012;Bhaskar et al., 2013).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Mutschler et al., 2012
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · cited 1×
“…use disorders identification text (Babor et al., 1992 [48); BMI = body mass index; FTND = Fagerström Test for Nicotine Dependence (level of nicotine dependence, Heatherton et al., 1991 [32; German version: Bleich et al., 2002 [49); STAI = State-Trait Anxiety Inventory (Spielberger, 1970 [37).”
Background(2001) · Cited by 5,455
Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details.
Pascual-Marqui, R. D. (2002) · PubMed · Cited by 4,070
Manual for the state-trait anxiety inventory (form Y) : "self-evaluation questionnaire"
Spielberger, C. D., Gorsuch, R. L., & Lushene, R. E. (1970) · Consulting Psychologists Press eBooks · Cited by 2,352
Estimates of global mortality attributable to smoking in 2000
Ezzati, M., & Lopez, A. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14338-3 · Cited by 1,247
Genome-wide meta-analyses identify multiple loci associated with smoking behavior
The Tobacco and Genetics Consortium (2010) · Nature Genetics · doi:10.1038/ng.571 · Cited by 1,098
A standardized boundary element method volume conductor model
Fuchs, M., Kastner, J., Wagner, M., Hawes, S., & Ebersole, J. S. (2002) · Clinical Neurophysiology · doi:10.1016/s1388-2457(02)00030-5 · Cited by 999
Self-citation
Research works printed but not linked: 2
- 10.1056%2FNEJMra0809890 · DOI · Paper page
- 10.1016%2Fj.nut.2008.06.007 · DOI
Cited by
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“…were found between SNPs of the NPY Y2 receptor (NPY2R) gene and alcohol dependence, alcohol withdrawal symptoms, tobacco addiction, comorbid alcohol and cocaine dependence, and cocaine dependence (Wetherill et al., 2008; Okahisa et al., 2009; Mutschler et al., 2012; Bhaskar et al., 2013).”
BackgroundIndividual differences in the neuropsychopathology of addiction
George, O., & Koob, G. F. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/gkoob · Cited by 138
Existing and future drugs for the treatment of the dark side of addiction
Koob, G. F., & Mason, B. J. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103143 · Cited by 121
Neuropeptide Y (NPY) and posttraumatic stress disorder (PTSD): A translational update
Schmeltzer, S. N., Herman, J. P., & Sah, R. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.06.020 · Cited by 110
“Interestingly, the rs16147 polymorphism described above for stress and anxiety is also associated with increased risk for tobacco dependence (Mutschler et al., 2012).”
Dieler, A. C., Dresler, T., Joachim, K., Deckert, J., Herrmann, M. J., & Fallgatter, A. J. (2014) · European Addiction Research · doi:10.1159/000357941 · Cited by 66
Metadata
- Authors
- Mutschler, J., Abbruzzese, E., von der Goltz, C., Dinter, C., Mobascher, A., Thiele, H., Diaz-Lacava, A., Dahmen, N., Gallinat, J., Majic, T., Petrovsky, N., Kornhuber, J., Thuerauf, N., Gründer, G., Brinkmeyer, J., Wienker, T., Wagner, M., Winterer, G., & Kiefer, F.
- Affiliations
- Heidelberg University (DE)
- Psychiatrische Universitätsklinik Zürich (CH)
- Johannes Gutenberg University Mainz (DE)
- University of Cologne (DE)
- Stiftung Charité (DE)
- University of Bonn (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- RWTH Aachen University (DE)
- Heinrich Heine University Düsseldorf (DE)
- ORCID
- Venue
- European Addiction Research
- Publisher
- S. Karger AG
- Published
- 2012
- Volume
- 18
- Issue
- 5
- Pages
- 246-252
- ISSN
- 1022-6877 (ISSN-L)
- 1421-9891
- OpenAlex
- W2025401097
- Cited by
- 17
- References
- 50
- Citations by year
- 2025: 1 · 2020: 1 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 2
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- European Addiction Research (publishedVersion)
- PubMed (publishedVersion)
- heiDOK (Heidelberg University) (acceptedVersion, other-oa)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- University Library Heidelberg
- Funders
- Deutsche Forschungsgemeinschaft (Wi1316/9-1, SPP1226)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- neuropeptide Y, single nucleotide polymorphisms, smoking, tobacco dependence, genetic susceptibility, state anxiety, brain reward system
- MeSH terms
- Adult, Alleles, Anxiety, Female, Gene Frequency, Genotype, Humans, Male, Middle Aged, Neuropeptide Y, Promoter Regions, Genetic, Smoking, Tobacco Use Disorder, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.